Global Insights on New Clinical Practice Guideline for the Treatment of Malignant Pleural Mesothelioma

HLA LOH As an Immune Evasive Mechanism in TRACERx NSCLC

NCCN Guidelines Updated for 2018: Keeping Pace with Data

Highlights of the 8th Edition of the TNM Staging System: Practicalities and Tools

The Lung Master Protocol: Results and Updates

The Role for Trimodality Therapy in Stage III NSCLC

Exploring Barriers to Combined-Modality Therapy for LS-SCLC

Oncologic Biologic Biosimilars Are Coming to Market: Are You Ready?

European Perspective on ALCHEMIST

Management of Pulmonary Nodules Detected by CT Screening

Improved Turnaround Times for NGS Wait on Improved Technology

IASLC 18th WCLC Special Session Provides Overview of Updated Guidelines for Molecular Testing